Safety Study of MultiGeneAngio in Patients With Chronic Critical Limb Ischemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Sam L. Teichman, MD
Independent consultant
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Barzilai Medical Center
Ashkelon, Israel
- Soroka Medical Center
Beersheba, Israel
- Rambam Medical Center
Haifa, Israel
- Hadassah University Hospital, Ein Kerem
Jerusalem, Israel
- Shaare Zedek Medical Center
Jerusalem, Israel
- Kaplan Medical Center
Rehovot, Israel
- Chaim Sheba Medical Center
Tel Litwinsky, Israel
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2010
- Primary completion
- 31 Aug 2011
- Completion
- 31 May 2026
- Last update posted
- 5 Mar 2015
- Registered enrollment
- 28
- Registry id
- NCT00956332
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.